NO20006153L - Poly(ADP-ribose)polymerase gen - Google Patents

Poly(ADP-ribose)polymerase gen

Info

Publication number
NO20006153L
NO20006153L NO20006153A NO20006153A NO20006153L NO 20006153 L NO20006153 L NO 20006153L NO 20006153 A NO20006153 A NO 20006153A NO 20006153 A NO20006153 A NO 20006153A NO 20006153 L NO20006153 L NO 20006153L
Authority
NO
Norway
Prior art keywords
methods
effectors
adp
ribose
poly
Prior art date
Application number
NO20006153A
Other languages
English (en)
Norwegian (no)
Other versions
NO20006153D0 (no
Inventor
Michael Kock
Thomas Hoeger
Burkhard Kroeger
Bernd Otterbach
Wilfried Lubisch
Hans-Georg Lemaire
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO20006153D0 publication Critical patent/NO20006153D0/no
Publication of NO20006153L publication Critical patent/NO20006153L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1077Pentosyltransferases (2.4.2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y204/00Glycosyltransferases (2.4)
    • C12Y204/02Pentosyltransferases (2.4.2)
    • C12Y204/0203NAD+ ADP-ribosyltransferase (2.4.2.30), i.e. tankyrase or poly(ADP-ribose) polymerase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/91091Glycosyltransferases (2.4)
    • G01N2333/91142Pentosyltransferases (2.4.2)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
NO20006153A 1998-06-05 2000-12-04 Poly(ADP-ribose)polymerase gen NO20006153L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19825213 1998-06-05
DE19908837 1999-03-01
PCT/EP1999/003889 WO1999064572A2 (de) 1998-06-05 1999-06-04 Poly(adp-ribose) polymerase-gene

Publications (2)

Publication Number Publication Date
NO20006153D0 NO20006153D0 (no) 2000-12-04
NO20006153L true NO20006153L (no) 2001-02-02

Family

ID=26046644

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006153A NO20006153L (no) 1998-06-05 2000-12-04 Poly(ADP-ribose)polymerase gen

Country Status (24)

Country Link
US (3) US7754459B1 (zh)
EP (1) EP1082416B1 (zh)
JP (1) JP2002517231A (zh)
KR (1) KR20010052582A (zh)
CN (1) CN1304446A (zh)
AR (1) AR020326A1 (zh)
AT (1) ATE358175T1 (zh)
AU (1) AU4605999A (zh)
BG (1) BG105018A (zh)
BR (1) BR9910967A (zh)
CA (1) CA2330206C (zh)
CO (1) CO5070700A1 (zh)
DE (1) DE59914280D1 (zh)
ES (1) ES2285842T3 (zh)
HK (1) HK1038591A1 (zh)
HR (1) HRP20010013A2 (zh)
HU (1) HUP0103190A2 (zh)
ID (1) ID27819A (zh)
IL (1) IL139750A0 (zh)
NO (1) NO20006153L (zh)
PL (1) PL345334A1 (zh)
SK (1) SK17892000A3 (zh)
TR (1) TR200003624T2 (zh)
WO (1) WO1999064572A2 (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19921567A1 (de) 1999-05-11 2000-11-16 Basf Ag Verwendung von Phthalazine-Derivaten
CN1370238A (zh) 1999-06-16 2002-09-18 艾科斯有限公司 人聚(adp-核酸)聚合酶2的物质和方法
ATE372337T1 (de) 2000-02-01 2007-09-15 Abbott Gmbh & Co Kg Heterozyklische verbindungen und deren anwendung als parp-inhibitoren
ZA200800907B (en) 2005-07-18 2010-04-28 Bipar Sciences Inc Treatment of cancer
US7994222B2 (en) 2006-09-05 2011-08-09 Bipar Sciences, Inc. Monitoring of the inhibition of fatty acid synthesis by iodo-nitrobenzamide compounds
JP2010502730A (ja) 2006-09-05 2010-01-28 バイパー サイエンシズ,インコーポレイティド 癌の治療法
JP2011503111A (ja) 2007-11-12 2011-01-27 バイパー サイエンシズ,インコーポレイティド Parp阻害剤単独又は抗腫瘍剤との組み合わせによる乳がんの治療
US20130330308A1 (en) 2011-02-18 2013-12-12 Dupont Nutrition Biosciences Aps Feed additive composition
GB201102857D0 (en) 2011-02-18 2011-04-06 Danisco Feed additive composition
GB201102865D0 (en) 2011-02-18 2011-04-06 Danisco Feed additive composition
GB201213801D0 (en) 2012-08-03 2012-09-12 Dupont Nutrition Biosci Aps Feed additive composition
MX367081B (es) 2012-08-29 2019-08-05 Sangamo Biosciences Inc Modificación genética mediada por nucleasas para usarse en el tratamiento de una condición genética.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162508A (en) * 1987-12-18 1992-11-10 Compagnie Oris Industrie Rare earth cryptates, processes for their preparation, synthesis intermediates and application as fluorescent tracers
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
FR2707011A1 (en) 1993-06-25 1994-12-30 Pasteur Sanofi Diagnostics Immunological process for the detection and assay of antibodies directed against poly(ADP-ribose) polymerase, application to diagnosis, kit for its implementation
DE4444949C1 (de) * 1994-12-16 1996-11-21 Deutsches Krebsforsch Vektoren und Viren zur Gentherapie

Also Published As

Publication number Publication date
HUP0103190A2 (hu) 2001-12-28
US20160010067A1 (en) 2016-01-14
ES2285842T3 (es) 2007-11-16
JP2002517231A (ja) 2002-06-18
ATE358175T1 (de) 2007-04-15
NO20006153D0 (no) 2000-12-04
US9051553B2 (en) 2015-06-09
CA2330206A1 (en) 1999-12-16
CO5070700A1 (es) 2001-08-28
EP1082416B1 (de) 2007-03-28
TR200003624T2 (tr) 2001-06-21
CN1304446A (zh) 2001-07-18
BR9910967A (pt) 2001-02-13
EP1082416A2 (de) 2001-03-14
AU4605999A (en) 1999-12-30
CA2330206C (en) 2010-04-13
DE59914280D1 (en) 2007-05-10
HRP20010013A2 (en) 2001-12-31
BG105018A (en) 2001-12-31
ID27819A (id) 2001-04-26
US20110107444A1 (en) 2011-05-05
IL139750A0 (en) 2002-02-10
US7754459B1 (en) 2010-07-13
WO1999064572A3 (de) 2000-06-08
AR020326A1 (es) 2002-05-08
HK1038591A1 (zh) 2002-03-22
WO1999064572A2 (de) 1999-12-16
PL345334A1 (en) 2001-12-17
SK17892000A3 (sk) 2001-09-11
KR20010052582A (ko) 2001-06-25

Similar Documents

Publication Publication Date Title
NO20006153L (no) Poly(ADP-ribose)polymerase gen
DE69942451D1 (de) Methode zum schnellen identifizieren von kleinen organischen liganden
NO962991L (no) Zink-finger-proteinderivater og fremgangsmåter derav
EE200100340A (et) Meetod signaali võimendamiseks, meetod kogu sihtnukleiinhappemolekuli või selle osa sekveneerimiseks, reaktiivikomplekt ja meetod sihtnukleiinhappemolekuli kaardistamiseks
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
FI962247A (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
WO2004005513A3 (en) Methods for specifically inhibiting histone deacetylase-7 and 8
WO1996039429A3 (en) Serum protein produced exclusively in adipocytes
DE69838724D1 (de) Polymerase-verbessernder faktor (pef)-enthaltende extrakte, pef proteinkomplexe, isoliertes pef protein und verfahren zur reinigung und identifizierung
DE69531309D1 (de) Entwurf diskontinuierlicher sonden unter verwendung von hybritopemapping
DK1025237T3 (da) Human kontrolpunktskinase, hCDS1, præparater og fremgangsmåder
CA2317816A1 (en) Peptide detection method
DE69826493D1 (de) Ikk-alpha proteine, nukleinsäuren und verfahren
Tjian et al. Purification and comparative properties of the delta and sigma subunits of RNA polymerase from Bacillus subtilis
Arden et al. Identification of serine/threonine protein kinases secreted by Trichinella spiralis infective larvae
DK0877758T3 (da) Oprenset SR-p70-protein
ATE373717T1 (de) Pde8a und seine verwendung
DE60025011D1 (de) Dna polymerase lambda und ihre verwendungen
WO2000058521A3 (en) Methods for the identification of reporter and target molecules using comprehensive gene expression profiles
WO2002033084A3 (en) Identification of the dombrock blood group glycoprotein as a polymorphic member of the adp-ribosyltransferase gene family
Bulygin et al. Protein environment of mRNA at the decoding site of 80S ribosomes from human placenta as revealed from affinity labeling with mRNA analogs–derivatives of oligoribonucleotides
DE60025336D1 (de) Verfahren und kit zur früherkennung von krebs
EP0856582A3 (en) Inhibitor protein of transcription factors and its DNA
Betz et al. Detection and identification of Vav1 protein in primary cultured murine cerebellar neurons and in neuroblastoma cells (SH-SY5Y and Neuro-2a)
WO2002074930A3 (en) Trans inteins for protein domain shuffling and biopolymerization

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application